Modern Pharmaceutics Vol 2: Applications and Advances (Record no. 15880)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01743nam a2200205Ia 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 140223b2009 xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781420065664 |
Terms of availability | 0.00 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.14 |
Item number | MOD |
245 ## - TITLE STATEMENT | |
Title | Modern Pharmaceutics Vol 2: Applications and Advances |
250 ## - EDITION STATEMENT | |
Edition statement | 5th ed |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | London |
Name of publisher, distributor, etc | Informa Healthcare |
Date of publication, distribution, etc | 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 537p |
440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
Title | Drugs and the Pharmaceutical Sciences Vol. 188 |
9 (RLIN) | 108946 |
500 ## - GENERAL NOTE | |
General note | Volume 2 discusses the applications and approaches in advanced drug delivery systems, including transdermal, pulmonary, and ocular routes. In addition, it describes the impact of the shift to personalized medicines in the fields of pharmaceutical biotechnology, pharmacogenomics, and nanotechnology.DELIVERY OF DRUGS BY THE PULMONARY ROUTE - Covers the interaction between the physical chemistry of the formulations and administered particles with the anatomy of the bronchial and alveolar regions.PEDIATRIC AND GERIATRIC PHARMACEUTICS - Addresses the physiological changes, design, and production of formulations for each of these patient populations.BIOEQUIVALENCE EVALUATION - Covers how to measure the bioequivalence of the same drug in quick-release tablet, capsule, or sustained-release form, as well as branded and generic systems.TARGET-ORIENTED DELIVERY SYSTEMS - Explores the challenges of designing delivery systems that target specific sites in the body and cause fewer side effects through interaction with non-diseased tissues |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
Personal name | Pharmaceutics |
9 (RLIN) | 108947 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Florence, Alexander T. |
Relator term | Editor |
9 (RLIN) | 108948 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Siepmann, Juergen |
Relator term | Editor |
9 (RLIN) | 108949 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Item type | Book |
995 ## - RECOMMENDATION 995 [LOCAL, UNIMARC FRANCE] | |
Origin of item (home branch) (free text) | Pharmacy Reference |
Genre | P0006999 |
Section | 615.14 |
Recipient parent organisation code | P0006999 |
No items available.